Michel Vounatsos - 19 Jan 2022 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Chief Executive Officer, Director
Signature
/s/ Wendell Taylor, attorney-in-fact for Michel Vounatsos
Issuer symbol
BIIB
Transactions as of
19 Jan 2022
Net transactions value
$0
Form type
4
Filing time
21 Jan 2022, 15:45:42 UTC
Previous filing
10 May 2021
Next filing
14 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Award $0 +10,594 +20% $0.000000 63,666 19 Jan 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2019. The shares will vest on February 12, 2022.
F2 Includes 102.902 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2021.